1. PD-025Hand-foot syndrome is a biomarker of improved survival following treatment with capecitabine. (2nd July 2019) Authors: Jandu, H; Church, D; Paul, J; Tomlinson, I; Iveson, T; Kerr, R; Kerr, D; Palles, C Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P-039ToxNav germline genetic testing and PROMinet digital mobile application toxicity monitoring: results of a prospective single centre clinical utility study (PRECISE STUDY). (2nd July 2019) Authors: Lee, L; Starkey, T; Sivakumar, S; Fotheringham, S; Mozolowski, G; Shearwood, V; Palles, C; Camilleri, P; Kerr, R; Kerr, D Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P-213An evaluation of the clinical utility of a panel of variants in DPYD and ENOSF1 for predicting common capecitabine related toxicities. (20th June 2018) Authors: Palles, C; Fotheringham, S; Chegwidden, L; Lucas, M; Mozolowski, G; Tomlinson, I; Kerr, D Journal: Annals of oncology Issue: Volume 29(2018)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Predictors of ambulance use in patients with acute myocardial infarction in Australia. Issue 12 (27th November 2006) Authors: Kerr, D; Holden, D; Smith, J; Kelly, A-M; Bunker, S Journal: Emergency medicine journal Issue: Volume 23:Issue 12(2006) Page Start: 948 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Trial of mefruside. Issue 5793 (15th January 1972) Authors: Kerr, D Journal: BMJ Issue: Volume 1:Issue 5793(1972) Page Start: 176 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. TERC polymorphisms are associated both with susceptibility to colorectal cancer and with longer telomeres. Issue 2 (27th June 2011) Authors: Jones, A M; Beggs, A D; Carvajal-Carmona, L; Farrington, S; Tenesa, A; Walker, M; Howarth, K; Ballereau, S; Hodgson, S V; Zauber, A; Bertagnolli, M; Midgley, R; Campbell, H; Kerr, D; Dunlop, M G; Tomlinson, I P M Journal: Gut Issue: Volume 61:Issue 2(2012) Page Start: 248 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Do we need to measure total serum IgA to exclude IgA deficiency in coeliac disease?. Issue 7 (17th February 2006) Authors: Sinclair, D; Saas, M; Turk, A; Goble, M; Kerr, D Journal: Journal of clinical pathology Issue: Volume 59:Issue 7(2006) Page Start: 736 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. New consultant contract: the shelf or the bin?. Issue 6182 (14th July 1979) Authors: Kerr, D Journal: BMJ Issue: Volume 2:Issue 6182(1979) Page Start: 135 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Course of brittle diabetes: 12 year follow up. Issue 6787 (25th May 1991) Authors: Tattersall, R; Gregory, R; Selby, C; Kerr, D; Heller, S Journal: BMJ Issue: Volume 302:Issue 6787(1991) Page Start: 1240 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. How is deep vein thrombosis diagnosed and managed in UK and Australian emergency departments?. Issue 11 (21st October 2005) Authors: Sampson, F C; Goodacre, S; Kelly, A-M; Kerr, D Journal: Emergency medicine journal Issue: Volume 22:Issue 11(2005) Page Start: 780 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗